“…There is growing evidence suggesting that chronic low-grade inflammation, or inflammation, could play a key role in the development of sarcopenia [ 4 , 5 , 7 , 10 , 15 , 16 , 17 , 18 ]. Thus, high blood level of proinflammatory biomarkers, including IL-6, IL-8, and IL-15, can affect skeletal muscle mass and are suggestive of inflammation, whereas high blood level of anti-inflammatory biomarkers, i.e., IL-4, IL-10, and IL-15 can counteract the generation and activity of proinflammatory cytokines and consequently the muscle atrophy and sarcopenia [ 5 , 10 , 17 , 18 , 19 , 20 , 21 , 22 ].…”